Jeff Frelick is Chief Executive Officer of Bone Biologics Corp. Currently has a direct ownership of 17,204 shares of BBLG, which is worth approximately $21,505. The most recent transaction as insider was on Sep 11, 2023, when has been sold 9,500 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $6,554. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.2K
0% 3M change
0% 12M change
Total Value Held $21,505

Jeff Frelick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2023
BUY
Open market or private purchase
$6,554 $0.69 p/Share
9,500 Added 35.58%
17,204 Common Stock
Aug 31 2023
BUY
Open market or private purchase
$5,016 $0.66 p/Share
7,600 Added 49.66%
7,704 Common Stock
JF

Jeff Frelick

Chief Executive Officer
Burlington, MA

Track Institutional and Insider Activities on BBLG

Follow Bone Biologics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBLG shares.

Notify only if

Insider Trading

Get notified when an Bone Biologics Corp insider buys or sells BBLG shares.

Notify only if

News

Receive news related to Bone Biologics Corp

Track Activities on BBLG